Tolfenamic acid VMD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

15,650 results for “Tolfenamic acid VMD”

Trials

View all 10267 →

Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks

24 participants · First posted Feb 5, 2020

Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation

First posted Jun 9, 2014

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

111 participants · First posted Jun 9, 2026

Drugs

View all 3094 →

Tolfenamic acid

C₁₄H₁₂ClNO₂

Copper-tolfenamic acid

VMD-30283

Organizations

View all 110 →

Shanghai Ajinomoto Amino Acid Co., Ltd.

China

Suzhou Fushilai Pharmaceutical Co.,Ltd.

Galmed Pharmaceuticals

Israel

News

View all 2179 →

EMA's CVMP Recommends New Veterinary Medicines and Updates Guidelines

VMD Launches Digital Pharmacovigilance Reporting Platform for Animal Medicines Industry

CT-Based VMD Biomarker Predicts Gastric Cancer Survival, Offering Path to Personalized Treatment

Page 1 of 1565